LAUREN RIKER, the Senior Vice President of $PCRX, sold 5,578 shares of the company on 06-04-2025 for an estimated $146,199. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.6% of their shares of this class of stock. Following this trade, they now own 59,564 shares of this class of $PCRX stock.
$PCRX Insider Trading Activity
$PCRX insiders have traded $PCRX stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PCRX stock by insiders over the last 6 months:
- KRISTEN WILLIAMS (Chief Administrative Officer) sold 14,376 shares for an estimated $377,226
- LAUREN RIKER (Senior Vice President, Finance) sold 5,578 shares for an estimated $146,208
- JONATHAN SLONIN (Chief Medical Officer) sold 879 shares for an estimated $16,173
- DARYL GAUGLER (Chief Operating Officer) sold 500 shares for an estimated $9,880
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PCRX Hedge Fund Activity
We have seen 115 institutional investors add shares of $PCRX stock to their portfolio, and 144 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 2,661,169 shares (-81.6%) from their portfolio in Q1 2025, for an estimated $66,130,049
- ALYESKA INVESTMENT GROUP, L.P. added 1,308,086 shares (+inf%) to their portfolio in Q1 2025, for an estimated $32,505,937
- CITADEL ADVISORS LLC added 1,282,548 shares (+2700.8%) to their portfolio in Q1 2025, for an estimated $31,871,317
- MILLENNIUM MANAGEMENT LLC removed 1,139,887 shares (-76.7%) from their portfolio in Q1 2025, for an estimated $28,326,191
- BALYASNY ASSET MANAGEMENT L.P. added 1,131,239 shares (+260.5%) to their portfolio in Q1 2025, for an estimated $28,111,289
- POINT72 ASSET MANAGEMENT, L.P. removed 1,075,673 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $26,730,474
- UBS GROUP AG removed 952,957 shares (-69.3%) from their portfolio in Q1 2025, for an estimated $23,680,981
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
